{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:34:18Z","timestamp":1770712458283,"version":"3.49.0"},"reference-count":90,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1080\/23744235.2025.2604034","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T13:56:16Z","timestamp":1766584576000},"page":"252-266","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Swedish guidelines for the management and treatment of patients with hepatitis D (delta) virus infection 2025"],"prefix":"10.1080","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8483-6504","authenticated-orcid":false,"given":"Johan","family":"Ringlander","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Sahlgrenska University Hospital","place":["Gothenburg, Sweden"]},{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]},{"name":"The Swedish Reference Group for Antiviral Therapy (RAV)","place":["Stockholm, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo","family":"Aleman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Karolinska University Hospital","place":["Stockholm, Sweden"]},{"name":"Department of Medicine Huddinge, Infectious Diseases, Karolinska Institute","place":["Stockholm, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Sofi","family":"Duberg","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Faculty of Medicine and Health, \u00d6rebro University","place":["\u00d6rebro, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Eilard","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Fischler","sequence":"additional","affiliation":[{"name":"CLINTEC, Karolinska Institutet","place":["Stockholm, Sweden"]},{"name":"Department of Pediatrics, Karolinska University Hospital","place":["Stockhom, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habiba","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Karolinska University Hospital","place":["Stockholm, Sweden"]},{"name":"Department of Medicine Huddinge, Infectious Diseases, Karolinska Institute","place":["Stockholm, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kampmann","sequence":"additional","affiliation":[{"name":"Deparment of Infectious Diseases, Sk\u00e5ne University Hospital Lund","place":["Lund, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Lindahl","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Karolinska University Hospital","place":["Stockholm, Sweden"]},{"name":"Department of Medicine Huddinge, Infectious Diseases, Karolinska Institute","place":["Stockholm, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Lindh","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Sahlgrenska University Hospital","place":["Gothenburg, Sweden"]},{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Westin","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Sahlgrenska University Hospital","place":["Gothenburg, Sweden"]},{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg","place":["Gothenburg, Sweden"]},{"name":"The Swedish Reference Group for Antiviral Therapy (RAV)","place":["Stockholm, Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital","place":["Gothenburg, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.10.6124"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90823-t"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.8.3819-3827.2002"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323888"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314713"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiae045"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13356"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2018.01.011"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02221-17"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan0241"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00430-14"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/286535a0"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/v12050538"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15655"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1125139"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14020198"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.041"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100813"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2023.05.008"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15776"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100547"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12564"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2019.1675903"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.008"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.10.043"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31214"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-021-00693-2"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.12.028"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.06.038"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1323628"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz633"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(82)90156-8"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15521"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.3.420"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01324.x"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13577"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.001"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13777"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.08.008"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.05.023"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.02.021"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15602"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30663-7"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27102"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.5754\/hge10126"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2007.00875.x"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2016.1175310"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912696"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.05.001"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.01.035"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-BASL.146"},{"issue":"3","key":"e_1_3_2_54_1","first-page":"A101","article-title":"P132 Continued treatment of early nonresponders or partial virologic responders with bulevirtide monotherapy in patients with chronic hepatitis delta (CHD) through week 96 leads to improvement in virologic and biochemical responses","volume":"72","author":"Lampertico P","year":"2023","unstructured":"Lampertico P, Wedemeyer H, Brunetto M, et al. P132 Continued treatment of early nonresponders or partial virologic responders with bulevirtide monotherapy in patients with chronic hepatitis delta (CHD) through week 96 leads to improvement in virologic and biochemical responses. Gut. 2023;72(Suppl 3):A101.","journal-title":"Gut"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000847"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15408"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100686"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.12.023"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.12.044"},{"issue":"1","key":"e_1_3_2_60_1","first-page":"S1828","article-title":"Predictors of undetectable hepatitis delta virus RNA at 48 weeks after end of treatment with bulevirtide monotherapy in the MYR301 study. Presented at: EASL Congress 2025; 2025 Jun 4\u20138; Amsterdam, Netherlands","volume":"82","author":"Aleman SB","year":"2025","unstructured":"Aleman SB, Brunetto M, Blank A, et al. Predictors of undetectable hepatitis delta virus RNA at 48 weeks after end of treatment with bulevirtide monotherapy in the MYR301 study. Presented at: EASL Congress 2025; 2025 Jun 4\u20138; Amsterdam, Netherlands. J Hepatol. 2025;82(Suppl 1):S1828.","journal-title":"J Hepatol"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2024.01.047"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15010137"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.07.037"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29888"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(25)00313-7"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.06.010"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0618-8278(19)30141-0"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2314134"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70008"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12494"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(23)00451-8"},{"key":"e_1_3_2_72_1","unstructured":"Replicor. [cited 2025 Feb 1]. Available from: www.replicor.com"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1633"},{"issue":"5","key":"e_1_3_2_74_1","first-page":"817","article-title":"Extended follow-up in the REP 301 and REP 401 studies demonstrates durable clinical benefit from NAP therapy","volume":"28","author":"Bazinet M","year":"2024","unstructured":"Bazinet M, Pantea V, Placinta G, et al. Extended follow-up in the REP 301 and REP 401 studies demonstrates durable clinical benefit from NAP therapy. Global Hepatitis Summit. 2024;28(5):817\u2013825.","journal-title":"Global Hepatitis Summit"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12112177"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332597"},{"key":"e_1_3_2_77_1","volume-title":"Safety and efficacy of REP 2139-Mg in hepatitis D patients: reporting of extended follow-up data from the international compassionate use program. AASLD 2024 Nov 15\u201319 Nov 2024","author":"Stern C.","year":"2024","unstructured":"Stern C. Safety and efficacy of REP 2139-Mg in hepatitis D patients: reporting of extended follow-up data from the international compassionate use program. AASLD 2024 Nov 15\u201319 Nov 2024. San Diego, CA: Hepatology; 2024."},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(23)00487-7"},{"key":"e_1_3_2_79_1","unstructured":"RiboCure Pharmaceuticals. Innovating for a healthier tomorrow: RiboCure\u2019s role in transforming liver disease treatment with siRNA. [cited 2025 Feb 1]. Available from: https:\/\/ribocure.com\/innovating-for-a-healthier-tomorrow-ribocures-role-in-transforming-liver-disease-treatment-with-sirna\/"},{"key":"e_1_3_2_80_1","volume-title":"Presented at AASLD\u2013The Liver Meeting","author":"Agarwal K","year":"2025","unstructured":"Agarwal K, Dobryanska M, Jucov A, et al. BJT-778, anti-HBsAg monoclonal antibody, achieved 100% virologic response in subjects with chronic hepatitis D (CHD): phase 2 study results. Presented at AASLD\u2013The Liver Meeting; 2025. Abstract."},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2508827"},{"key":"e_1_3_2_82_1","unstructured":"Hepatitis B\u2013disease statistics\u2014Public Health Agency of Sweden; 2024 [cited 2025 Feb 1]. Available from: https:\/\/www.folkhalsomyndigheten.se\/folkhalsorapportering-statistik\/statistik-a-o\/sjukdomsstatistik\/hepatit-b\/"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.1.4"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.3390\/life14030348"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000859"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(06)80017-x"},{"issue":"12","key":"e_1_3_2_87_1","first-page":"735","article-title":"Interferon-alpha treatment of children and young adults with chronic hepatitis delta virus (HDV) infection","volume":"21","author":"Aziz S","year":"2011","unstructured":"Aziz S, Rajper J, Noor-Ul-Ain W, et al. Interferon-alpha treatment of children and young adults with chronic hepatitis delta virus (HDV) infection. J Coll Phys Surg Pak. 2011;21(12):735\u2013740.","journal-title":"J Coll Phys Surg Pak"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.1996.tb00002.x"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1255"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13556"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00361-w"}],"container-title":["Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/23744235.2025.2604034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T03:09:41Z","timestamp":1770001781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/23744235.2025.2604034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1080\/23744235.2025.2604034"],"URL":"https:\/\/doi.org\/10.1080\/23744235.2025.2604034","relation":{},"ISSN":["2374-4235","2374-4243"],"issn-type":[{"value":"2374-4235","type":"print"},{"value":"2374-4243","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=infd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=infd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}